Patent · US Active

Anti-EGFR antibodies and antibody drug conjugates

US9827330B2 · kind B2 · utility

2Cited by

10References

21Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

Edward B. Reilly · Libertyville, US
Andrew C. Phillips · Libertyville, US
Lorenzo Benatuil · Northborough, US
Chung-Ming Hsieh · Newton, US
Jennifer M. Perez · Worcester, US

Key dates

Filing date	Nov 11, 2016
Grant date	Nov 28, 2017
Priority date	—
Expiry date	Nov 11, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to anti-epidermal growth factor (EGFR) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.